Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Protagonist Therapeutics, Inc (PTGX)  
$29.61 0.29 (0.99%) as of 4:30 Tue 5/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 57,680,000
Market Cap: 1.71(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $14.05 - $32.15
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Protagonist Therapeutics is a clinical-stage biopharmaceutical company with various peptide-based new chemical entities in different stages of development, all derived from Co.'s proprietary technology platform. Co.'s clinical programs address two main categories of diseases; hematology and blood disorders, and inflammatory and immunomodulatory diseases. Co.'s main clinical asset, rusfertide (generic name for PTG-300) is an injectable hepcidin mimetic in development for the potential treatment of erythrocytosis, iron overload and other blood disorders. PN-943 is an investigational, orally delivered, gut-restricted alpha-4-beta-7 specific integrin antagonist for inflammatory bowel disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 93,396 175,244 175,244 175,244
Total Sell Value $2,858,339 $4,519,351 $4,519,351 $4,519,351
Total People Sold 3 5 5 5
Total Sell Transactions 6 9 9 9
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 166
  Page 6 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Shame Richard S Chief Medical Officer   •       –      –    2017-12-22 4 AS $20.50 $72,345 D/D (3,529) 0     -
   Shame Richard S Chief Medical Officer   •       –      –    2017-12-22 4 OE $4.21 $14,857 D/D 3,529 3,529     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2017-12-21 4 AS $19.56 $160,570 D/D (8,210) 190,437     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2017-12-21 4 OE $1.89 $15,517 D/D 8,210 198,647     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2017-12-20 4 AS $19.55 $34,987 D/D (1,790) 190,437     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2017-12-20 4 OE $1.89 $3,383 D/D 1,790 192,227     -
   Liu David Y Chief Scientific Officer   •       –      –    2017-12-18 4 AS $20.00 $17,500 D/D (875) 3,822     -
   Liu David Y Chief Scientific Officer   •       –      –    2017-12-18 4 OE $1.89 $1,654 D/D 875 4,697     -
   Oneil Thomas P. Chief Financial Officer   •       –      –    2017-12-18 4 AS $20.00 $160,000 D/D (8,000) 0     -
   Oneil Thomas P. Chief Financial Officer   •       –      –    2017-12-18 4 OE $1.16 $21,480 D/D 8,000 8,000     -
   Liu David Y Chief Scientific Officer   •       –      –    2017-11-30 4 AS $20.00 $17,500 D/D (875) 3,822     -
   Liu David Y Chief Scientific Officer   •       –      –    2017-11-30 4 A $1.89 $1,654 D/D 875 4,697     -
   Liu David Y Chief Scientific Officer   •       –      –    2017-11-13 4 AS $16.97 $118,761 D/D (7,000) 3,822     -
   Liu David Y Chief Scientific Officer   •       –      –    2017-11-13 4 OE $1.89 $21,350 D/D 7,000 7,322     -
   Shame Richard S Chief Medical Officer   •       –      –    2017-10-05 4 AS $19.00 $38,323 D/D (2,017) 0     -
   Shame Richard S Chief Medical Officer   •       –      –    2017-10-05 4 OE $4.21 $8,492 D/D 2,017 2,017     -
   Shame Richard S Chief Medical Officer   •       –      –    2017-09-12 4 AS $14.31 $52,753 D/D (3,687) 0     -
   Shame Richard S Chief Medical Officer   •       –      –    2017-08-29 4 AS $17.00 $25,704 D/D (1,512) 1,865     -
   Shame Richard S Chief Medical Officer   •       –      –    2017-08-29 4 OE $4.21 $6,366 D/D 1,512 3,377     -
   Liu David Y Chief Scientific Officer   •       –      –    2017-08-28 4 AS $15.00 $52,500 D/D (3,500) 2,000     -
   Liu David Y Chief Scientific Officer   •       –      –    2017-08-28 4 OE $4.21 $14,735 D/D 3,500 5,500     -
   Liu David Y Chief Scientific Officer   •       –      –    2017-07-10 4 AS $12.68 $44,380 D/D (3,500) 2,000     -
   Liu David Y Chief Scientific Officer   •       –      –    2017-07-10 4 OE $1.89 $6,615 D/D 3,500 5,500     -
   Gross Phillip 10% Owner   –       –       •   2017-05-30 3 IO $0.00 $0 I/I 0 2,056,076     -
   Giraudo Bryan Director   –       •      –    2017-05-16 4 B $6.46 $64,566 D/D 10,000 10,000 2.39     -
  166 Records found
  1  2  3  4  5  6  7   
  Page 6 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us